title: Oxidative stress, HDL functionality and effects of intravenous iron administration in women with iron deficiency anemia.
abstract: Iron deficiency anemia (IDA) affects around 20-30% of adults worldwide. An association between IDA and cardiovascular disease (CVD) has been reported. Oxidative stress, inflammation and low concentration of high-density lipoproteins (HDL) were implicated on endothelial dysfunction and CVD in IDA. We studied the effects of iron deficiency and of an intravenous iron administration on oxidative stress and HDL characteristics in IDA women.
  
  
  
  Two studies in IDA women are presented: a case-control study, including 18 patients and 18 age-matched healthy women, and a follow-up study 72hr after the administration of intravenous iron (n = 16). Lipids, malondialdehyde, cholesteryl ester transfer protein (CETP), paraoxonase-1 (PON-1) and HDL chemical composition and functionality (cholesterol efflux and antioxidative activity) were measured. Cell cholesterol efflux from iron-deficient macrophages to a reference HDL was also evaluated.
  
  
  
  IDA patients showed higher triglycerides and CETP activity and lower HDL-C than controls (all p < 0.001). HDL particles from IDA patients showed higher triglyceride content (+30%,p < 0.05) and lower antioxidative capacity (-23%,p < 0.05). Although HDL-mediated cholesterol efflux was similar between the patients and controls, iron deficiency provoked a significant reduction in macrophage cholesterol efflux (-25%,p < 0.05). Arylesterase activity of PON-1 was significantly lower in IDA patients than controls (-16%,p < 0.05). The intravenous administration of iron was associated with a decrease in malondialdehyde levels and an increase in arylesterase activity of PON-1 (-22% and +18%, respectively, p < 0.05).
  
  
  
  IDA is associated with oxidative stress and functionally deficient HDL particles. It remains to be determined if such alterations suffice to impair endothelial function in IDA.
authors.affiliation: Laboratory of Lipids and Atherosclerosis, School of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, CONICET, Buenos Aires, Argentina. Electronic address: tomasmero@yahoo.com.ar.
authors.forename: Tomás
authors.initials: T
authors.lastname: Meroño
authors.affiliation: National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie - Paris 6, AP-HP, Groupe Hospitalier Pitié-Salpétrière, Paris, F-75013, France.
authors.forename: Carolane
authors.initials: C
authors.lastname: Dauteuille
authors.affiliation: Laboratory of Lipids and Atherosclerosis, School of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, CONICET, Buenos Aires, Argentina.
authors.forename: Walter
authors.initials: W
authors.lastname: Tetzlaff
authors.affiliation: Laboratory of Lipids and Atherosclerosis, School of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, CONICET, Buenos Aires, Argentina.
authors.forename: Maximiliano
authors.initials: M
authors.lastname: Martín
authors.affiliation: Laboratory of Lipids and Atherosclerosis, School of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, CONICET, Buenos Aires, Argentina.
authors.forename: Eliana
authors.initials: E
authors.lastname: Botta
authors.affiliation: National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie - Paris 6, AP-HP, Groupe Hospitalier Pitié-Salpétrière, Paris, F-75013, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Lhomme
authors.affiliation: Central Laboratory, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
authors.forename: María Soledad
authors.initials: MS
authors.lastname: Saez
authors.affiliation: Central Laboratory, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
authors.forename: Patricia
authors.initials: P
authors.lastname: Sorroche
authors.affiliation: Laboratory of Lipids and Atherosclerosis, School of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, CONICET, Buenos Aires, Argentina.
authors.forename: Laura
authors.initials: L
authors.lastname: Boero
authors.affiliation: Hematology Division, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
authors.forename: Jorge
authors.initials: J
authors.lastname: Arbelbide
authors.affiliation: National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie - Paris 6, AP-HP, Groupe Hospitalier Pitié-Salpétrière, Paris, F-75013, France.
authors.forename: M John
authors.initials: MJ
authors.lastname: Chapman
authors.affiliation: National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie - Paris 6, AP-HP, Groupe Hospitalier Pitié-Salpétrière, Paris, F-75013, France.
authors.forename: Anatol
authors.initials: A
authors.lastname: Kontush
authors.affiliation: Laboratory of Lipids and Atherosclerosis, School of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, CONICET, Buenos Aires, Argentina.
authors.forename: Fernando
authors.initials: F
authors.lastname: Brites
mesh_terms: D061605:Administration, Intravenous; D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000188:drug therapy*; D043303:Aryldialkylphosphatase / Q000097:blood; D002265:Carboxylic Ester Hydrolases / Q000097:blood; D016022:Case-Control Studies; D053480:Cholesterol Ester Transfer Proteins / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007501:Iron / Q000008:administration & dosage* / Q000097:blood; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D018384:Oxidative Stress / Q000187:drug effects*; D014280:Triglycerides / Q000097:blood
chemical_list: C506642:CETP protein, human; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides; D008315:Malondialdehyde; D007501:Iron; D002265:Carboxylic Ester Hydrolases; C019734:arylesterase; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human
keywords: HDL; Iron; Iron deficiency anemia; Lipoproteins; Oxidative stress; Paraoxonase